Comparative molecular analyses of esophageal cancer: Adenocarcinoma vs. squamous cell carcinomas and impact on outcome


Mohamed E. Salem, Joanne Xiu, Shaheer A. Khan, Hongkun Wang, Brandon G. Smaglo, Wafik S. El-Deiry, Jimmy J. Hwang, Michael J. Pishvaian, Emil Lou, Anthony F. Shields, Philip A. Philip, Zoran Gatalica, Sandeep K. Reddy, John Marshall


Patients (pts) with esophageal cancer (EsophCa) have a poor prognosis and limited treatment options. The effect of histological subtype on tumor molecular profile remains unknown. Here we aim to compare the molecular aberrations in esophageal adenocarcinoma (EAC) and squamous cell carcinoma (ESCC).

Download Publication